UNCY · NASDAQ · Biotechnology

Unicycive Therapeutics

Develops kidney-disease candidates for dialysis and acute injury.

$5.32
After-hours close+0.06 (+1.14%)
At close$5.26(−4.36%)

Breakdown13F · Form 4

Institutions 37.10%9.91M sharesInsiders 6.70%1.79M sharesOther 56.20%15.00M shares

Shares outstanding 26.70M · Float 24.28M · 90.9% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Vivo Opportunity Fund Holdings, L.P.6.10M9.99%13GNov 14, 2025
RA Capital Management, L.P.2.80M9.90%13GMay 15, 2026
Vivo Capital, LLC1.79M6.70%13FMay 20, 2026
Gaurav Aggarwal · director1.79M6.70%Form 4Aug 26, 2025
BlackRock, Inc.1.41M5.30%13GJul 30, 2026

Institutions13F, as of Mar 31, 2026

57 holders · 9.91M shares · 19 new positions · 31 increased · 10 reduced · 4 closed

HolderShares% outstandingChg q/qFiled
Vivo Capital, LLC1.79M6.70%0May 20, 2026
Millennium Management LLC1.40M5.24%+384.5KMay 15, 2026
Octagon Capital Advisors LP1.00M3.75%0May 15, 2026
Nantahala Capital Management, LLC939.2K3.52%0May 15, 2026
Vanguard Capital Management LLC811.4K3.04%+811.4KnewMay 15, 2026
Great Point Partners LLC796.6K2.98%0May 15, 2026
Logos Global Management LP473.6K1.77%0May 15, 2026
Citadel Advisors LLC236.8K0.89%−21.5KMay 15, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Nantahala Capital Management, LLC9.99%2.28M13GFeb 13, 2026
Vivo Opportunity Fund Holdings, L.P.9.99%6.10M13GNov 14, 2025
Great Point Partners, LLC9.99%13GFeb 14, 2025
RA Capital Management, L.P.9.90%2.80M13GMay 15, 2026
Octagon Capital Advisors LPincl. Octagon Investments Master Fund LP, Octagon Private Opportunities Fund II LP +1 more9.10%13GOct 11, 2024
Biotechnology Value Fund L P5.70%777.3K13GAug 14, 2025
Integrated Core Strategies (US) LLC5.50%1.17M13GJan 23, 2026
BlackRock, Inc.5.30%1.41M13GJul 30, 2026
Walleye Capital LLC5.30%Nov 13, 2024

InsidersForm 4

InsiderRoleShares% outstandingFiled
Gaurav Aggarwaldirector1.79M6.70%Aug 26, 2025

6 people have not refiled in the last 18 months (287.8K shares), so they are not in the figure above

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.